Last reviewed · How we verify

NCT03580213

Hand Therapy or Not Following Collagenase Treatment for Dupuytren's Contracture?

Completed NA Last updated 22 September 2023
What this trial tests

NA trial testing Hand therapy MCPJ affected in Dupuytren Disease of Palm and Finger, With Contracture in 72 participants. Completed in 3 May 2023.

Timeline
5 April 2018
Primary endpoint
3 May 2023
3 May 2023

Quick facts

Lead sponsorHaukeland University Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment72
Start date5 April 2018
Primary completion3 May 2023
Estimated completion3 May 2023
Sites1 location across Norway

Drugs / interventions tested

Conditions studied

Sponsor

Haukeland University Hospital

Who can join

Eligibility, any sex, with Dupuytren Disease of Palm and Finger, With Contracture. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates if hand therapy have an impact on the patients' preformance of and satisfaction with everyday activities or not following collagenase injection treatment for Dupuytren's contracture. Differences on this between patients with contracted proximal interphalangeal joint(s) and patients with affected metacarpophalangeal joint(s) only, will also be investigated. Two equal sized groups will either receive hand therapy or no treatment following the injection and extension procedure.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Hand therapy or not following collagenase treatment for Dupuytren's contracture? Protocol for a randomised controlled trial.
    Aglen T, Matre KH, Lind C, Selles RW, et al · · 2019 · cited 4× · PMID 31455312 · DOI 10.1186/s12891-019-2712-z

Verify or expand the search:

Other Haukeland University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03580213.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing